Free Trial

Virtu Financial LLC Invests $515,000 in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background
Remove Ads

Virtu Financial LLC acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 972 shares of the company's stock, valued at approximately $515,000.

Several other institutional investors have also modified their holdings of the company. Blueshift Asset Management LLC purchased a new stake in Chemed during the fourth quarter valued at about $460,000. Teacher Retirement System of Texas increased its position in Chemed by 3.9% in the 4th quarter. Teacher Retirement System of Texas now owns 18,778 shares of the company's stock worth $9,949,000 after purchasing an additional 711 shares during the last quarter. Xponance Inc. raised its stake in shares of Chemed by 5.5% during the 4th quarter. Xponance Inc. now owns 1,973 shares of the company's stock worth $1,045,000 after purchasing an additional 103 shares in the last quarter. Boston Partners grew its stake in shares of Chemed by 51.3% in the 4th quarter. Boston Partners now owns 17,070 shares of the company's stock valued at $9,046,000 after buying an additional 5,787 shares in the last quarter. Finally, CBIZ Investment Advisory Services LLC increased its holdings in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Transactions at Chemed

In related news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.32% of the company's stock.

Remove Ads

Analysts Set New Price Targets

CHE has been the subject of several recent research reports. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada increased their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th.

Read Our Latest Analysis on CHE

Chemed Price Performance

Shares of NYSE CHE traded down $6.42 during trading hours on Friday, hitting $605.94. 162,388 shares of the stock were exchanged, compared to its average volume of 93,565. The firm has a market capitalization of $8.87 billion, a P/E ratio of 30.62, a P/E/G ratio of 2.15 and a beta of 0.43. Chemed Co. has a one year low of $512.12 and a one year high of $642.68. The company's 50 day moving average is $574.16 and its 200 day moving average is $566.66.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads